Premium
BridgeBio Pharma Inc (BBIO)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Derma... BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy. The company focus on genetic diseases because they exist at the intersection of high unmet patient need and tractable biology. Show more
- Remarkable early Attruby demand: 430 scripts written by 248 unique HCPs since FDA approval with broad uptake across academic centers and community centers in all patient types - Fully enrolled...
PALO ALTO, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases...
The Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of acoramidis in the EU based on positive results from the Phase 3 ATTRibute-CM study; final approval...
- Attruby is the first and only approved product with a label specifying near-complete stabilization of TTR. Attruby has been shown to preserve the native function of TTR as a transport protein of...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 2.295 | 6.72921858965 | 34.105 | 37.755 | 34.12 | 2207416 | 36.43322198 | CS |
| 4 | 8.9 | 32.3636363636 | 27.5 | 37.755 | 27.32 | 2902811 | 33.58665059 | CS |
| 12 | 11.39 | 45.5417832867 | 25.01 | 37.755 | 21.72 | 2426163 | 28.89120743 | CS |
| 26 | 9.32 | 34.4165435746 | 27.08 | 37.755 | 21.72 | 2114232 | 27.53570512 | CS |
| 52 | -0.04 | -0.109769484083 | 36.44 | 41.04 | 21.62 | 1958960 | 28.00160763 | CS |
| 156 | 27.5 | 308.988764045 | 8.9 | 44.32 | 4.98 | 2121653 | 20.47319632 | CS |
| 260 | 1.4 | 4 | 35 | 73.5 | 4.98 | 1724954 | 24.56531913 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
